To Evaluate Safety and Effectiveness of RovatitanTab.

A Multicenter, Single-arm, Prospective, Observational Study to Evaluate the Safety and Effectiveness of a Fixed-dose Combination Containing Valsartan and Rosuvastatin (Rovatitan® Tablet) in Patient With Hypertension and Hypercholesterolemia

To evaluate the safety and effectiveness of a fixed-dose combination containing valsartan and rosuvastatin (Rovatitan® Tablet) in patient with hypertension and hypercholesterolemia

• Effectiveness: the ratio of patients who reach target BP or LDL-cholesterol
• Safety: we will collect safety data

Inclusion Criteria:

• Patients who have hypertension and hyperlipidemia and older than 19 years
• Patients who undertstand purpose and method of study, agree with study

Exclusion Criteria:

• Patients who have been administered Rosuvastatin/Valsartan as a anti- hyperlipiddemic/anti-hypertensive drugs
• Uncontrolled hypertension (SBP>=180mmHg or DBP>=110mmHg)
• Patients who participated another clinical study or observational study 3 months ago.